Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds a potential therapeutic opportunity in regulatory T cells' resilience to the loss ...

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Zidesamtinib targets ROS1+ NSCLC patients with prior TKI treatment, addressing CNS-penetrant treatment challenges and ...

Dr. Jilmil Satish Raina has joined the Mohawk Valley Health System (MVHS) Immune Health and Prevention office.

NOVEMBER 20, 2025, NEW YORK - Ludwig Cancer Research is delighted to announce that Richard White of the Oxford Branch of the Ludwig Institute for ...

The FDA accepted a new drug application for zidesamtinib for previously treated locally advanced or metastatic ROS1-positive ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

New Penn State study finds higher incidence of skin cancers in south central Pa. Connections to farming are raised ...

Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard ...

Ramaiah Memorial Hospital & Ramaiah Medical College host Global WBMT Symposium on Cell Therapy: Our Bureau, Bengaluru Friday, November 21, 2025, 13:30 Hrs [IST] Ramaiah Memorial H ...